Self-perceived HIV risk, learning about pre-exposure
prophylaxis (PrEP) via trusted sources, positive healthcare experiences and
health insurance coverage are facilitators of PrEP initiation and continuation
for at-risk minority women, according to research conducted in New York City
and published in the Journal of the Association of Nurses in AIDS Care.
The investigators identified three distinct phases
When a friend stays over, I notice the flash glance in the morning as I dole out my PrEP meds, hormones and vitamins from my divider and down them with citrus juice. Silence doesn’t ‘always’ speak volumes but in this case it does.
Dr. Robert Grant developed a treatment — a daily pill known as pre-exposure prophylaxis, or PrEP — that could stop the AIDS crisis. We look at why that hasn’t happened.
The government has decided to allow reimbursement for Gilead’s Truvada (tenofovir disoproxil fumarate/emtricitabine) for pre-exposure prophylaxis (PrEP).
The Ministry of Health and Welfare on Tuesday said it would grant insurance benefit for Truvada HIV-1 PrEP used for people who are negative in HIV-1 infection but at high risk due to sex with an HIV-positive partner, starting from June 7.
Democratic Sen. Scott Wiener has proposed a bill that would allow people to receive their first 30 days of PrEP over the counter if they first receive counseling and an HIV test. But the bill faces opposition from the California Medical Association, which represents doctors, and major insurance companies.
PrEP has become more affordable at London’s leading sexual health clinic.
The 56 Dean Street clinic opened its PrEP Shop in February last year and provides the HIV preventative medication for those eligible for NHS care. It will cost as little as £17.50 per month.
Rather than prescribe F/TDF as PrEP, Michael Saag, MD said, prescribers should sidestep the brand-name product and instead give their PrEP-eligible patients a generic HIV drug combination that uses lamivudine (3TC) with TDF.
To combat the stigma surrounding PrEP use, Pennsylvania state Rep. Brian Sims, D-Philadelphia, the first openly gay man to be elected to the Pennsylvania legislature, recently shared a photo of himself holding an FTC/TDF pill on Instagram.
It’s not the cost of PrEP that keeps more patients from accessing it; it’s the lack of awareness and the daunting nature of our complicated healthcare system.
Qualitative research published in the July issue of Social Science & Medicine by Dr Katherine Quinn and colleagues
at the Center for AIDS Intervention Research highlights how intersectional stigma
contributes to low pre-exposure prophylaxis (PrEP) uptake for black men who
have sex with men (MSM) in the US. Mistreatment in healthcare services, racism,
homophobia and
Two years ago, the Opposites
Attract study found no transmissions between 343 regular gay couples of
differing HIV status where the HIV-positive partner had a viral load under 200
copies/ml, the negative partner was not taking pre-exposure prophylaxis (PrEP), and they did not use a condom. In doing so, alongside the PARTNER
study, it
Analysis of men who acquired HIV in the deferred arm of the
PROUD study highlights two risk factors that are far more important than any
others. “A recent history of syphilis or rectal chlamydia/gonorrhoea, or
multiple ncRAI [receptive anal intercourse without a condom] partners indicates a high
imminent risk of HIV infection,” Ellen White
Black men who have sex
with men (MSM) in London experience a unique set of motivations and barriers to
using pre-exposure prophylaxis (PrEP), according to the results of a recent
qualitative study published in Sexually
Transmitted Infections. This research was carried out by T. Charles Witzel
and colleagues at the London School of Hygiene and
A study of gay and
bisexual men diagnosed with recently acquired hepatitis C infection and treated
in three English clinics has found that 40% of them were HIV negative,
the 25th Annual Conference of the British HIV Association (BHIVA) was
told in Bournemouth this week, though all the HIV-negative men were in London.Daniel Bradshaw of
A combination of the drugs raltegravir and lamivudine produced acceptable drug levels in both women and men, in rectal and vaginal tissues, suggesting that the two drugs could provide an effective alternative to tenofovir-based pre-exposure prophylaxis (PrEP), the 25th Annual Conference of the British HIV Association (BHIVA) heard in Bournemouth yesterday.Dr
The recent report on the first year of the implementation
of pre-exposure prophylaxis (PrEP) through the National Health Service (NHS) in Scotland concludes: “Year one has been a resounding success in terms of establishing a
new nationwide service – the first of its type in the UK and one of the first
worldwide.”
In
A point-of-care
urine test can accurately determine if a person is adherent to tenofovir-based
pre-exposure prophylaxis (PrEP), according to research presented to the recent Conference on Retroviruses and Opportunistic Infections (CROI 2019) in Seattle. The
test checks for antibodies to tenofovir and was tested in a trial of 30 people in Thailand who
Two studies in monkeys of experimental pre-exposure prophylaxis
(PrEP) regimens featuring the drug tenofovir alafenamide (TAF) produced differing
results when presented at last week’s Conference on Retroviruses and Opportunistic Infections (CROI 2019) in Seattle. As a third study suggested,
the results may partly be due to the way TAF is absorbed into cells.
TAF
